October 26, 2015
Anavex joins NASDAQ
Anavex Life Sciences Corp., has announced it would be trading its common stock on the NASDAQ, an American/Canadian stock exchange, one…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
October 26, 2015
Medicine for treating pancreatic cancer approved in US
The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat…
October 26, 2015
Cosentyx in Europe for psoriatic arthritis and ankylosing spondylitis
Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Cosentyx(TM) (secukinumab)…
October 21, 2015
Prevalence of Marijuana Use Among U.S. Adults Doubles Over Past Decade
The percentage of Americans who reported using marijuana in the past year more than doubled between 2001-2002 and 2012-2013, and the increase in marijuana use disorder during that time was nearly as large.
October 21, 2015
Dechra closes Genera takeover
Dechra has announced that on the closing date of its Takeover Offer to acquire the shares in Genera not owned by…
October 20, 2015
$22.9 million in Planning Grants for Certified Community Behavioral Health Clinics
The Substance Abuse and Mental Health Services Administration (SAMHSA), in conjunction with the Centers for Medicare & Medicaid Services (CMS) and the Assistant Secretary of Planning and Evaluation (ASPE), today awarded a total of $22.9 million to support states throughout the nation in their efforts to improve behavioral health of their citizens by providing community-based mental and substance use disorder treatment.
October 20, 2015
HHS: New members of Advisory Council on Alzheimer’s Research, Care, and Services
Secretary of U.S. Department of Health & Human Services (HSS) Sylvia M. Burwell on Tuesday announced six new members to serve on the Advisory Council on Alzheimer’s Research, Care, and Services.
October 19, 2015
Allergen wraps up AqueSys buy (Including $300M up-front payment)
Allergan plc has completed the acquisition of AqueSys, Inc. a clinical-stage medical device company focused on developing ocular implants that…
October 19, 2015
Shire disappointed, wating lifitegrast, OPUS-3 study, data
“We were disappointed, but will soon have data from the Phase 3 study, OPUS 3,” said Flemming Ornskov, M.D., CEO, Shire.
October 16, 2015
FDA: Blood thinners can prevent strokes
Blood thinner (anticoagulant) can reduce the risk of a stroke by 50% to 60% for people who have atrial fibrillation.